Related references
Note: Only part of the references are listed.Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report
Lauri M. Burroughs et al.
BLOOD (2020)
Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome
Lucia Sereni et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Gene therapy for Wiskott-Aldrich syndrome: here to stay
Fabio Candotti
LANCET HAEMATOLOGY (2019)
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study
Francesca Ferrua et al.
LANCET HAEMATOLOGY (2019)
Platelets are the Achilles' heel of Wiskott-Aldrich syndrome
Alain Fischer
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Regulation of differentiation of MEG01 to megakaryocytes and platelet-like particles by Valproic acid through Notch3 mediated actin polymerization
Ankita Dhenge et al.
PLATELETS (2019)
One hundred percent survival after transplantation of 34 patients with Wiskott-Aldrich syndrome over 20 years
Reem Ahmed Elfeky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult
Emma C. Morris et al.
BLOOD (2017)
Absence of WASp Enhances Hematopoietic and Megakaryocytic Differentiation in a Human Embryonic Stem Cell Model
Miguel G. Toscano et al.
MOLECULAR THERAPY (2016)
Lent-On-Plus Lentiviral vectors for conditional expression in human stem cells
Karim Benabdellah et al.
SCIENTIFIC REPORTS (2016)
Outcomes Following Gene Therapy in Patients With Severe Wiskott-Aldrich Syndrome
Salima Hacein-Bey Abina et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Platelet actin nodules are podosome-like structures dependent on Wiskott-Aldrich syndrome protein and ARP2/3 complex
Natalie S. Poulter et al.
NATURE COMMUNICATIONS (2015)
Uncovering and Dissecting the Genotoxicity of Self-inactivating Lentiviral Vectors In Vivo
Daniela Cesana et al.
MOLECULAR THERAPY (2014)
Use of zinc-finger nucleases to knock out the WAS gene in K562 cells: a human cellular model for Wiskott-Aldrich syndrome
Miguel G. Toscano et al.
DISEASE MODELS & MECHANISMS (2013)
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
Alessandro Aiuti et al.
SCIENCE (2013)
Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study
Daniele Moratto et al.
BLOOD (2011)
Lentiviral-mediated gene therapy leads to improvement of B-cell functionality in a murine model of Wiskott-Aldrich syndrome
Marita Bosticardo et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
c-Myb and GATA-1 alternate dominant roles during megakaryocyte differentiation
P. Garcia et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function
Michael P. Blundell et al.
DISEASE MARKERS (2010)
Was cDNA Sequences Modulate Transgene Expression of Was Promoter-Driven Lentiviral Vectors
Miguel G. Toscano et al.
HUMAN GENE THERAPY (2009)
Improved lentiviral vectors for Wiskott-Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis
C. Frecha et al.
GENE THERAPY (2008)
Hematopoietic-specific lentiviral vectors circumvent cellular toxicity due to ectopic expression of Wiskott-Aldrich syndrome protein
Miguel G. Toscano et al.
HUMAN GENE THERAPY (2008)
Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment
Siham Sabri et al.
BLOOD (2006)
The Wiskott-Aldrich syndrome
HD Ochs et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation
L Dupré et al.
HUMAN GENE THERAPY (2006)
Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences
F Martín et al.
GENE THERAPY (2005)
A lentiviral vector encoding the human Wiskott Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice
S Charrier et al.
GENE THERAPY (2005)
Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction
L Dupré et al.
MOLECULAR THERAPY (2004)
Gene regulation of Wiskott-Aldrich syndrome protein and the human homolog of the Drosophila Su(var)3-9:: WASP and SUV39H1, two adjacent genes at Xp11.23
TL Hagemann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2000)
The Wiskott-Aldrich syndrome
AJ Thrasher et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Share Paper
